Back

Examining the Role of Extrachromosomal DNA in 1,216 Lung Cancers

Khandekar, A.; Hoang, P. H.; Luebeck, J.; Diaz-Gay, M.; Zhao, W.; McElderry, J. P.; Hartman, C.; Miraftab, M.; Lee, O. W.; Barnao, K. M.; Bergstrom, E. N.; Yang, Y.; Nowak, M. A.; Rothman, N.; Homer, R.; Yang, S.-R.; Lan, Q.; Wedge, D. C.; Yang, L.; Chanock, S. J.; Zhang, T.; Alexandrov, L. B.; Landi, M. T.

2025-07-24 bioinformatics
10.1101/2025.06.03.657117 bioRxiv
Show abstract

The role of extrachromosomal DNA (ecDNA) in lung cancer, particularly in subjects who never smoked (LCINS), remains unclear. Examination of over 1200 whole-genome-sequenced lung cancers identified ecDNA in 18.9% of patients. Recurrent amplification of MDM2 and other oncogenes via ecDNA possibly drives a LCINS subset. Tumors harboring ecDNA showed worse overall survival than tumors harboring other focal amplifications. A strong association with whole-genome doubling suggests most ecDNA reflects genomic instability in treatment-naive lung cancer.

Published in JNCI: Journal of the National Cancer Institute · training set

Matching journals

The top 1 journal accounts for 50% of the predicted probability mass.

50% of probability mass above

"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.